UA104753C2 - 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate and polymorph - Google Patents

6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate and polymorph

Info

Publication number
UA104753C2
UA104753C2 UAA201110940A UAA201110940A UA104753C2 UA 104753 C2 UA104753 C2 UA 104753C2 UA A201110940 A UAA201110940 A UA A201110940A UA A201110940 A UAA201110940 A UA A201110940A UA 104753 C2 UA104753 C2 UA 104753C2
Authority
UA
Ukraine
Prior art keywords
hexahydrocyclohepta
chromen
oxo
sulfamate
polymorph
Prior art date
Application number
UAA201110940A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Натали Мондоли
Бертран Пойро
Анна Брочард
Жоэль Ричард
Дельфин Делайе
Кристиан ДИОЛЕ
Ален РОЛЛАН
Франсис Дианкор
Джерард Кокрель
Демьен Мартин
Жюли Линол
Офелия Хуссен
Мари-Ноэль Пети
Барри Виктор Ллойд Поттер
Лок Вай Лоуренс ВУ
Original Assignee
Ипсен Фарма С.А.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ипсен Фарма С.А.С. filed Critical Ипсен Фарма С.А.С.
Priority claimed from PCT/FR2010/000117 external-priority patent/WO2010092260A2/en
Publication of UA104753C2 publication Critical patent/UA104753C2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a solid pharmaceutical composition including the active principle 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate. The present invention also relates to polymorphs of the 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate compound.
UAA201110940A 2009-02-13 2010-02-12 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate and polymorph UA104753C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0900655A FR2942225B1 (en) 2009-02-13 2009-02-13 VARIETY I OF 6-OXO-6,7,8,9,10,11-HEXAHYDROCLYCLOHEPTA5 ° C! CHROMEN-3 YL SULFAMATE OF REDUCED GRANULOMETRY
PCT/FR2010/000117 WO2010092260A2 (en) 2009-02-13 2010-02-12 Pharmaceutical compositions of 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (c)chromen-3-yl sulfamate

Publications (1)

Publication Number Publication Date
UA104753C2 true UA104753C2 (en) 2014-03-11

Family

ID=41168544

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201110940A UA104753C2 (en) 2009-02-13 2010-02-12 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate and polymorph

Country Status (2)

Country Link
FR (1) FR2942225B1 (en)
UA (1) UA104753C2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9603325D0 (en) * 1996-02-16 1996-04-17 Imperial College A compound

Also Published As

Publication number Publication date
FR2942225A1 (en) 2010-08-20
FR2942225B1 (en) 2013-03-01

Similar Documents

Publication Publication Date Title
WO2009111653A3 (en) Antiviral therapeutic agents
MX2010005889A (en) Novel thiophene derivatives.
EP3699176A3 (en) Antiviral compounds
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
MY183312A (en) Pharmaceutical formulation
TN2013000253A1 (en) Bicyclo[3.2.1]octyl amide derivatives and uses of same
TW200801000A (en) Spiroindolinone derivatives
WO2010092090A3 (en) Novel salts of sitagliptin
TW200942524A (en) Novel aminomethyl benzene derivatives
MX2011008176A (en) 3, 3' -spiroindolinone derivatives as anticancer agents.
WO2010139981A3 (en) Processes for preparing crystalline forms of dasatinib
WO2009104021A3 (en) Novel polymorphs and processes for their preparation
MY187718A (en) Pharmaceutical formulations
IN2012DN03182A (en)
WO2011157722A3 (en) Solid ivabradine-containing composition
WO2011009938A3 (en) Stambomycin and derivatives, their production and their use as drugs
TW200942530A (en) Pyridine compounds
WO2012015681A3 (en) Drug-ligand conjugates, synthesis thereof, and intermediates thereto
WO2010049449A3 (en) Novel salts of sunitinib
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2011050054A3 (en) Coumarin compounds as receptor modulators with therapeutic utility
TN2012000105A1 (en) Spirolactam derivatives and uses of same
WO2010079045A3 (en) Crystalline salt forms of flibanserine
WO2009062659A3 (en) Polymorphs of enantiopure erdosteine
MA34580B1 (en) VALSARTAN HIGHLY CRYSTALLINE